Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_assertion description "[In breast cancers expressing estrogen receptors (ERs), level of CYP1B1 is increased by E2 and reversed by an estrogen receptor antagonist, ICI 182,780 or 4-hydrotamoxifen, which indicates that the expression of CYP1 family in downstream region of AhR is regulated by an activation of ER?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_assertion evidence source_evidence_literature NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_assertion SIO_000772 25448748 NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_assertion wasDerivedFrom befree-2016 NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_assertion wasGeneratedBy ECO_0000203 NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.
- befree-2016 importedOn "2016-02-19" NP1242369.RAD--fo8oPhHOeiKK9LLyX8QIrP1Gxgzhn0bKtfEswYkY130_provenance.